Granulocyte colony-stimulating factor receptor signaling: implications for G-CSF responses and leukemic progression

Ivo P Touw1, Karishma Palande, Renée Beekman

  • 1Department of Hematology, Erasmus University Medical Center, Dr Molewaterplein 50 3015 GE, Rotterdam, The Netherlands. i.touw@erasmusmc.nl

Insights

Granulocyte colony-stimulating factor receptor (G-CSFR) signaling involves lysosomal degradation after ligand activation. This review examines G-CSFR endosomal routing, ubiquitination, and mutations linked to neutropenia and leukemia.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Hematology

Background:

  • Cytokine receptors are internalized and degraded in lysosomes after ligand binding.
  • The granulocyte colony-stimulating factor receptor (G-CSFR) plays a critical role in neutrophil development and function.
  • Dysregulation of G-CSFR signaling is implicated in hematological disorders.

Purpose of the Study:

  • To review the signaling functions of the G-CSFR.
  • To explore the dynamics of G-CSFR endosomal routing and degradation.
  • To discuss the implications of G-CSFR mutations in severe congenital neutropenia and leukemic transformation.

Main Methods:

  • Literature review focusing on G-CSFR intracellular trafficking.
  • Analysis of mechanisms including receptor ubiquitination and phosphatase activity.
  • Examination of clinical data related to G-CSFR mutations and patient outcomes.

Main Results:

  • G-CSFR undergoes regulated endosomal trafficking to lysosomes for degradation following ligand activation.
  • Receptor lysine ubiquitination and redox-sensitive phosphatases are key regulators of G-CSFR signaling.
  • Specific G-CSFR mutations in neutropenia patients are associated with altered receptor dynamics and increased risk of leukemia.

Conclusions:

  • Understanding G-CSFR intracellular routing is crucial for deciphering its signaling.
  • Aberrant G-CSFR trafficking and signaling due to mutations contribute to severe congenital neutropenia and leukemogenesis.
  • Targeting G-CSFR pathways may offer therapeutic strategies for these conditions.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells: